anmelden
OMX Stockholm 30
3.115,98
PKT
+16,48
PKT
+0,53
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.01.15 | Ericsson (Telefon L.M.Ericsson) (B) Underweight | Barclays Capital | |
| 14.01.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 14.01.15 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 13.01.15 | Volvo (B) Equal weight | Barclays Capital | |
| 13.01.15 | ABB (Asea Brown Boveri) Neutral | Merrill Lynch & Co., Inc. | |
| 12.01.15 | Volvo (B) Neutral | Merrill Lynch & Co., Inc. | |
| 09.01.15 | AstraZeneca buy | UBS AG | |
| 08.01.15 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | Credit Suisse Group | |
| 08.01.15 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 05.01.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 15.12.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 11.12.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 11.12.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 11.12.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.12.14 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 09.12.14 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 09.12.14 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 05.12.14 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 03.12.14 | AstraZeneca Underweight | Morgan Stanley | |
| 01.12.14 | Volvo (B) Hold | Deutsche Bank AG | |
| 01.12.14 | Volvo (B) Outperform | Credit Suisse Group | |
| 26.11.14 | Volvo (B) Underweight | Morgan Stanley | |
| 26.11.14 | AstraZeneca buy | UBS AG | |
| 25.11.14 | AstraZeneca Outperform | BNP PARIBAS | |
| 21.11.14 | Volvo (B) Sell | S&P Capital IQ | |
| 19.11.14 | AstraZeneca Underweight | JP Morgan Chase & Co. | |
| 19.11.14 | AstraZeneca buy | Citigroup Corp. | |
| 18.11.14 | AstraZeneca buy | UBS AG | |
| 17.11.14 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 17.11.14 | AstraZeneca neutral | Barclays Capital | |
| 14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | Citigroup Corp. | |
| 14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Underweight | Barclays Capital | |
| 14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 14.11.14 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 13.11.14 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 13.11.14 | AstraZeneca Underweight | JP Morgan Chase & Co. | |
| 11.11.14 | Volvo (B) Sell | Goldman Sachs Group Inc. | |
| 10.11.14 | AstraZeneca buy | Jefferies & Company Inc. | |
| 07.11.14 | AstraZeneca neutral | Independent Research GmbH | |
| 07.11.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.